Damiano Bragantini

797 total citations
19 papers, 443 citations indexed

About

Damiano Bragantini is a scholar working on Infectious Diseases, Molecular Medicine and Pharmacology. According to data from OpenAlex, Damiano Bragantini has authored 19 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 5 papers in Molecular Medicine and 3 papers in Pharmacology. Recurrent topics in Damiano Bragantini's work include SARS-CoV-2 and COVID-19 Research (7 papers), Antibiotic Resistance in Bacteria (5 papers) and COVID-19 Clinical Research Studies (5 papers). Damiano Bragantini is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), Antibiotic Resistance in Bacteria (5 papers) and COVID-19 Clinical Research Studies (5 papers). Damiano Bragantini collaborates with scholars based in Italy, United States and Germany. Damiano Bragantini's co-authors include Gian Luca Salvagno, Giuseppe Lippi, Brandon Michael Henry, Fulvia Mazzaferri, Laura Pighi, Maurizio Sanguinetti, Elena Carrara, Simone De Nitto, Ercole Concia and F. Franceschi and has published in prestigious journals such as PLoS Computational Biology, Clinical Microbiology and Infection and International Journal of Antimicrobial Agents.

In The Last Decade

Damiano Bragantini

17 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Damiano Bragantini Italy 11 203 199 100 100 89 19 443
Flaminia Olearo Germany 12 234 1.2× 96 0.5× 118 1.2× 51 0.5× 49 0.6× 32 407
Banu Bayraktar Türkiye 14 156 0.8× 127 0.6× 135 1.4× 53 0.5× 31 0.3× 42 428
Jaime Lora‐Tamayo Spain 11 116 0.6× 203 1.0× 79 0.8× 76 0.8× 69 0.8× 35 411
Abdollah Karimi Iran 9 157 0.8× 153 0.8× 76 0.8× 57 0.6× 22 0.2× 67 389
S. Paltansing Netherlands 10 193 1.0× 278 1.4× 220 2.2× 73 0.7× 56 0.6× 16 573
Pedro Torres‐González Mexico 11 247 1.2× 124 0.6× 219 2.2× 55 0.6× 29 0.3× 29 450
Soo‐youn Moon South Korea 12 100 0.5× 136 0.7× 169 1.7× 113 1.1× 79 0.9× 28 426
Paola Del Giacomo Italy 9 83 0.4× 198 1.0× 87 0.9× 77 0.8× 94 1.1× 18 421
Yoko Takayama Japan 9 107 0.5× 128 0.6× 100 1.0× 30 0.3× 46 0.5× 42 348
R.H.T. Nijhuis Netherlands 11 128 0.6× 129 0.6× 115 1.1× 13 0.1× 28 0.3× 30 411

Countries citing papers authored by Damiano Bragantini

Since Specialization
Citations

This map shows the geographic impact of Damiano Bragantini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damiano Bragantini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damiano Bragantini more than expected).

Fields of papers citing papers by Damiano Bragantini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Damiano Bragantini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damiano Bragantini. The network helps show where Damiano Bragantini may publish in the future.

Co-authorship network of co-authors of Damiano Bragantini

This figure shows the co-authorship network connecting the top 25 collaborators of Damiano Bragantini. A scholar is included among the top collaborators of Damiano Bragantini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Damiano Bragantini. Damiano Bragantini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Salvagno, Gian Luca, Laura Pighi, Brandon Michael Henry, et al.. (2023). Assessment of humoral and cellular immunity after bivalent BNT162b2 vaccination and potential association with reactogenicity. Clinical Chemistry and Laboratory Medicine (CCLM). 61(7). 1343–1348. 1 indexed citations
2.
Bragantini, Damiano, et al.. (2022). A novel logical model of COVID-19 intracellular infection to support therapies development. PLoS Computational Biology. 18(8). e1010443–e1010443. 1 indexed citations
3.
Salvagno, Gian Luca, et al.. (2021). Clinical assessment of the Roche SARS-CoV-2 rapid antigen test. Diagnosis. 8(3). 322–326. 37 indexed citations
4.
Scudeller, Luigia, Elda Righi, Damiano Bragantini, et al.. (2021). Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli. International Journal of Antimicrobial Agents. 57(5). 106344–106344. 74 indexed citations
5.
Salvagno, Gian Luca, et al.. (2021). Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers. Journal of Medical Biochemistry. 40(4). 327–334. 17 indexed citations
6.
Savoldi, Alessia, Elena Carrara, Laura J. V. Piddock, et al.. (2021). The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies. BMC Infectious Diseases. 21(1). 545–545. 26 indexed citations
7.
Carrara, Elena, Alessia Savoldi, Laura J. V. Piddock, et al.. (2021). Clinical management of severe infections caused by carbapenem-resistant gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinations. Clinical Microbiology and Infection. 28(1). 66–72. 15 indexed citations
8.
Salvagno, Gian Luca, Brandon Michael Henry, Laura Pighi, et al.. (2021). Anti-SARS-CoV-2 Receptor Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination. SSRN Electronic Journal. 26 indexed citations
9.
Salvagno, Gian Luca, Brandon Michael Henry, Laura Pighi, et al.. (2021). Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination. Diagnostics. 11(5). 832–832. 63 indexed citations
10.
Comel, Andrea, Walter Mosaner, Damiano Bragantini, & Massimiliano Lanzafame. (2020). Rapid radiological improvement of COVID-19 pneumonia after treatment with tocilizumab. Infection. 49(1). 195–196. 1 indexed citations
11.
Lippi, Giuseppe, et al.. (2020). Clinical Assessment of the Roche SARS-CoV-2 Rapid Antigen Test. SSRN Electronic Journal. 1 indexed citations
12.
Tacconelli, Evelina, Fulvia Mazzaferri, Anne Marie G. A. de Smet, et al.. (2019). ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers. Clinical Microbiology and Infection. 25(7). 807–817. 123 indexed citations
13.
14.
Sozio, Emanuela, Filippo Pieralli, Anna Maria Azzini, et al.. (2018). A prediction rule for early recognition of patients with candidemia in Internal Medicine: results from an Italian, multicentric, case–control study. Infection. 46(5). 625–633. 11 indexed citations
15.
Carrara, Elena, Damiano Bragantini, & Evelina Tacconelli. (2018). Combination versus monotherapy for the treatment of infections due to carbapenem-resistant Enterobacteriaceae. Current Opinion in Infectious Diseases. 31(6). 594–599. 10 indexed citations
16.
Concia, Ercole, Damiano Bragantini, & Fulvia Mazzaferri. (2017). Clinical evaluation of guidelines and therapeutic approaches in multi drug-resistant urinary tract infections. Journal of Chemotherapy. 29(sup1). 19–28. 28 indexed citations
17.
Bragantini, Damiano, et al.. (2013). Beyond The Iron Triangle: Year Zero 1. 7 indexed citations
18.
Bragantini, Damiano, et al.. (2013). Beyond The Iron Triangle: Year One 1. 1 indexed citations
19.
Bragantini, Damiano. (2012). Il modello "Stakeholder shape". 32–37.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Flaminia Olearo Breakdown of academic impact, for papers by Banu Bayraktar Breakdown of academic impact, for papers by Jaime Lora‐Tamayo Breakdown of academic impact, for papers by Abdollah Karimi Breakdown of academic impact, for papers by S. Paltansing Breakdown of academic impact, for papers by Pedro Torres‐González Breakdown of academic impact, for papers by Soo‐youn Moon Breakdown of academic impact, for papers by Paola Del Giacomo Breakdown of academic impact, for papers by Yoko Takayama Breakdown of academic impact, for papers by R.H.T. Nijhuis
Rankless by CCL
2026